Selective serotonin reuptake inhibitors (SSRIs) may be powerful antidepressants, but they are also a source of potential risk for the children expecting mothers. A rise in the number of newborns with autism spectrum disorders (ASDs) has led medical professionals to consider whether mother-patient SSRI consumption may be partially responsible.
Initial findings are disquieting for many parents and families. In some SSRI medications, research has found that ASD risk jumped by as much as 200 percent for expecting mothers. To make matters worse, the risk correlation was highest during the first trimester, precisely when many patients do not realize they may be pregnant.
Worried that your SSRI prescription may be positively correlated with your infant’s illness? The time to act is now. Find out what additional questions you should ask and whether the attorneys at the law firm of Fears Nachawati may be able to help you. With years of experience and dedicated expertise, we know how to advise patients like you. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com.